This is an old revision of this page, as edited by Monkbot(talk | contribs) at 20:22, 19 October 2020(→top: Task 17: replace to-be-deprecated: |name-list-format= (1× replaced; usage: 1 of 1);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 20:22, 19 October 2020 by Monkbot(talk | contribs)(→top: Task 17: replace to-be-deprecated: |name-list-format= (1× replaced; usage: 1 of 1);)
Hydromadinone acetate (developmental code name NSC-33170), also known as chloroacetoxyprogesterone (CAP), as well as 6α-chloro-17α-acetoxyprogesterone or 6α-chloro-17α-acetoxypregn-4-ene-3,20-dione, is a steroidalprogestin of the 17α-hydroxyprogesterone group that was never marketed.[1][2] It is the C17α acetateester of hydromadinone, which, similarly, was never marketed.[1]